Latest Posts

The therapeutic potential of natural killer cells on everyone's lips

nk2019, jacques zimmer, tatiana michel, markus ollert, natural killer cells
From 30th September to 3rd October 2019, close to 500 scientists from all over the world gathered at the 18th edition of the NK Meeting.
October 16, 2019   In Our News  

Europe no longer wants accidents and injuries

eu safety, eurosafe, dritan bejko, injury prevention, retrace, accident prevention
Are we safe from accidents and injuries in Europe?
October 15, 2019   In Our News  

LIH cancer researcher awarded for best preclinical oral presentation

eano, anna golebiewska, simone niclou, glioblastoma, cancer stem cells
A strong representation of the NorLux Neuro-Oncology Laboratory from LIH’s Department of Oncology was present at the 14th annual meeting of the EANO.
October 10, 2019   In Our News  

Life Sciences and Euron PhD Days

This year’s PhD Days, held from 23rd to 25th September on the Belval Campus, combined a traditional Life Sciences PhD Day with the Euron conference.
October 01, 2019   In Our News  

Boosting research in digital epidemiology and e-health

guy fagherazzi, e-health, digital epidemiology, digital health, population health
In June 2019, Dr Guy Fagherazzi was appointed Research Leader of the “Digital Epidemiology and E-health hub”, a new strategic position at LIH.
September 20, 2019   In Our News  

LIH and Tolerogenics collaborate on immune tolerance-promoting therapies

markus ollert, tolerogenics, immune tolerance, autoimmune disease, allergic disease
The Luxembourg-based biotech start-up Tolerogenics is developing novel immunotherapies based on the induction of immune tolerance.
September 17, 2019   In Our News  

Innovative approach that makes “cold” tumours “hot”

sprint bioscience, bassam janji, vps34, autophagy, immunotherapy
A recent news article in Nature Reviews Drug Discovery highlights innovative approaches aiming to improve the efficiency of cancer immunotherapy.
September 09, 2019   In Our News  

Luxembourg’s hepatitis C screening and care in drug users selected as example of best practice in Europe

world hepatitis day, carole devaux, hepatitis c, drug users
The World Hepatitis Day on 28th July is an opportunity to raise awareness on the disease and on research conducted in this area.
July 25, 2019   In Our News  

Luxembourg Parkinson’s Study funded with an additional six million euros

parkinson, ncer-pd, patient stratification, patient empowerment, rejko krüger
The Luxembourg National Research Fund has committed an additional six million euros to the National Centre for Excellence in Research on Parkinson’s Disease.
July 23, 2019   In Our News  

Bringing biomedical research closer to the patient: appointments to strategic positions

rejko krüger, simone niclou, guy berchem, translational medicine
LIH is currently refining its research strategy to focus more on translational research, placing patients and the population at the centre of its activities.
July 11, 2019   In Our News  

Top Japanese research consolidates ties with Luxembourg

riken-ims, lcsb, ulf nehrbass, outpost labs
Representatives of the Japanese RIKEN Institute, the University of Luxembourg and LIH have signed a Memorandum of Understanding on 9th July 2019.
July 10, 2019   In Our News  

Biomarker identification for a better care of diabetic cardiomyopathy

diabetic cardiomyopathy, yvan devaux, biomarker identification, cardiateam
LIH is a partner in CARDIATEAM, a large translational research project funded by the Innovative Medicines Initiative IMI2.
July 09, 2019   In Our News  

LIH gut microbiome research as the cover story of a leading news magazine Der Spiegel

microbiome, mahesh desai, der spiegel, dietary fibre, markus ollert
Der Spiegel, published its latest cover story focussed on human gut microbiome research.
July 05, 2019   In Our News  

The Cancer Foundation supports a research project on a novel therapeutic protein for Glioblastoma

virginie neirinckx, simone niclou, glioblastoma, receptor tyrosine kinase, fondation cancer
The Cancer Foundation (Fondation Cancer) funds a research project on brain cancer at the NorLux Neuro-Oncology Laboratory in LIH’s Department of Oncology.
July 02, 2019   In Our News  

LIH allergology researchers distinguished at Europe's largest allergy conference

markus ollert, eaaci, allergology, christiane hilger
LIH was well represented at this year’s annual EAACI Congress to communicate on the successful projets in allergy research conducted in Luxembourg.
July 01, 2019   In Our News  

NextImmune PhD retreat 2019: insights into hot immunology topics

nextimmune, immunology, phd candidates, markus ollert, pride
The second scientific retreat of the Doctoral Training Unit (DTU) NextImmune took place at the Alvisse Parc Hotel in Luxembourg from 7th to 9th May 2019.
June 26, 2019   In Our News  

Philanthropy supporting cancer research

cancer research, philanthropy, oncolytic virus, virotherapy, antonio marchini
The Laboratory of Oncolytic Virus Immuno-Therapeutics (LOVIT) at LIH’s Department of Oncology received a generous private donation.
June 20, 2019   In Our News  

Affiliated Professorships with University of Luxembourg

ulf nehrbass, laetitia huiart, university of luxembourg, park-qc, e-health
Prof Ulf Nehrbass, CEO of LIH, and Prof Laetitia Huiart, Director of the Department of Population Health, have been appointed as affiliated professors.
June 06, 2019   In Our News  

Restoring the anti-tumour immune response - a new research project funded by the Cancer Foundation

fondation cancer, actin response, breast cancer, clément thomas
Luxembourg’s Cancer Foundation supports a new research project from LIH that aims to evaluate the effectiveness of targeting a new mechanism in cancer cells.
June 03, 2019   In Our News  

Cancer cells are quick-change artists adapting to their environment

Until now, researchers have assumed that the growth of solid tumours originates from cancer stem cells characterised by specific surface markers.
May 29, 2019   In Our News